1.Invasive Cervical Cancer in Women Aged 35 or Less.
Eun Hee CHYU ; Won Gue KIM ; Un Dong PARK
Korean Journal of Gynecologic Oncology and Colposcopy 1995;6(1):13-22
The incidence in women less than 35 years of age is increasing despite an overall decrease in newly diagnosed invasive cervieal cancer among all age groups. However the influence of young age on prognosis remains controversial. So 163 patients of invasive cervical cancer in women aged 35 or less treated from Jan. 1, 1984 to Dec. 31. 1993 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea, were studied retrospectively. We obtained the following results; The 5-year survival rates by clinical stage were 88.7Y% in stage I b, 71.5% in stage IIa, 31.2% in stage IIb and O% in stage III or above. The lymph node metastasis rates by stage in RAH group, were 21.3% in stage I b and 31.8% in stage IIa. The lymph nodc metastasis rates by lesion size in RAH group, were 19.2% in 2cm below, 20.7% in 2-4cm and 40.0% in 4cm above. The 5-year survival rates in RAH group were 74,9% in lymph node positive group and 89.0% in lymph node negative group. The recurrenee rates by clinieal stage were 0% in stage Ia, 20.6% in stage I b, 22.2% in stage IIa, 50.0% in stage Ilb and 90.9% in stage III or above.
Busan
;
Female
;
Gynecology
;
Humans
;
Incidence
;
Korea
;
Lymph Nodes
;
Neoplasm Metastasis
;
Obstetrics
;
Prognosis
;
Retrospective Studies
;
Survival Rate
;
Uterine Cervical Neoplasms*
2.10 Year's Expreience on Gestational Trophoblastic Disease.
Eun Hee CHYU ; Gun Sang YOO ; Won Gue KIM ; Un Dong PARK
Korean Journal of Gynecologic Oncology and Colposcopy 1996;7(2):84-92
For the clinical analysis and evaluation on the patients with gestational trophoblastic disease(GTD), a study was done retrospectively on 114 patients with GTD(60 in Hydatidiform mole, 10 in invasive mole, 44 in choriocarcinoma) treated from Jan. 1, 1985 to Dec. 31, 1994 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea. We obtained the following results ; The incidence of GTD was 1 per 73 deliveries in H. mole, 1 per 437 deliveries in invasive mole, and 1 per 99 deliveries in choriocarcinoma. The most prevalent age was 21-40 groups. Abnormal vaginal bleeding was a main symptom and sign. 30.6% of H. mole was managed by dilatation and curettage. 90.0% of invasive mole and 51.4% of choriocarcinoma were managed by surgical treatment and chemotherapy. The overall remissinon rate of choriocarcinoma was 71.4%(100.0% in stage I, 66.7% in stage II, 54.5% in stage III, 50.0% in stage IV).
Busan
;
Choriocarcinoma
;
Dilatation and Curettage
;
Drug Therapy
;
Female
;
Gestational Trophoblastic Disease*
;
Gynecology
;
Humans
;
Hydatidiform Mole
;
Hydatidiform Mole, Invasive
;
Incidence
;
Korea
;
Obstetrics
;
Pregnancy
;
Retrospective Studies
;
Trophoblasts
;
Uterine Hemorrhage
3.Diagnostic Conization of the Cerivx.
Gun Sang YOO ; Dong Hwi KIM ; Eun Hee CHYU ; Un Dong PARK
Korean Journal of Gynecologic Oncology and Colposcopy 1996;7(2):77-83
To evaluate the effectiveness of conization in the diagnosis of cervical cancer, the histopathologic finding of 464 consecutive cases were analized with respect to the cytology, punch biopsy and hysterectomy. Cold knife conization was performed under direct visualization(naked eye conization) from January, 1987 to Octorber 1994 at department of Obstetrics and Gynecology, Kosin Medical Center. The results were summerized as follows : 1. The rate of agreement and underdiagnosis of between pap smear and naked eye conization were 43.7% and 47%. 2. The rate of agreement and underdiagnosis of between punch biopsy and naked eye conization were 64.5% and 21.8% 3. Subsequent hysterectomy was done on the 382 case and their incidence of residual disease rate was 44.2%(169 cases). Their incidence of residual lesion was increased with severity of the carcinomatous change. 4. The rate of complication undergoing conization was 8.4%(39 cases).
Biopsy
;
Conization*
;
Diagnosis
;
Gynecology
;
Hysterectomy
;
Incidence
;
Obstetrics
;
Uterine Cervical Neoplasms